Qingdao Baheal Medical INC. (SHE:301015)

SHE:301015 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Net Income	513.61	474.69	691.59	712.06	502.09	421.64
Depreciation & Amortization	102.21	102.21	86.02	86.14	54.86	41.18
Other Amortization	27.78	27.78	6.2	5.27	6.67	12.01
Loss (Gain) From Sale of Assets	-0.52	-0.52	-0.93	6.57	-0.57	-0.1
Asset Writedown & Restructuring Costs	0.6	0.6	0.46	0.35	0.04	0.01
Loss (Gain) From Sale of Investments	-96.77	-96.77	-56.85	-48.5	8.87	-9.77
Provision & Write-off of Bad Debts	7.92	7.92	11.26	32.87	13.08	-1.53
Other Operating Activities	-68.04	247.97	163.65	128.92	36.81	56.33
Change in Accounts Receivable	150.19	150.19	-85.14	-104.15	-386.9	-373.68
Change in Inventory	-11.69	-11.69	-70.23	-57.96	-70.37	-10.89
Change in Accounts Payable	61.81	61.81	64.5	49.02	148.45	39.62
Change in Other Net Operating Assets	-	-	-	-	-	0.2
Operating Cash Flow	657.38	934.45	813.85	799.5	305.75	181.3
Operating Cash Flow Growth	-24.13%	14.82%	1.80%	161.48%	68.65%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Capital Expenditures	-309.23	-288.93	-303.99	-185.49	-105.32	-27.49
Sale of Property, Plant & Equipment	0.4	0.4	0.79	6.09	0.91	0.13
Cash Acquisitions	-	-	-3.39	-	-5.76	-
Divestitures	-	-	4.43	16.35	7.78	6.11
Investment in Securities	-274.2	-307.98	-437.83	-137.39	-18.24	-4.48
Other Investing Activities	8.15	7.7	7.68	4.73	3.3	2.9
Investing Cash Flow	-574.88	-588.81	-732.32	-295.71	-117.33	-22.82

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Short-Term Debt Issued	-	-	-	68.43	1,571	1,188
Long-Term Debt Issued	-	2,416	2,198	1,434	-	-
Total Debt Issued	2,798	2,416	2,198	1,503	1,571	1,188
Short-Term Debt Repaid	-	-	-304.96	-21.1	-1,530	-1,374
Long-Term Debt Repaid	-	-1,295	-938.63	-1,460	-33.82	-26.09
Total Debt Repaid	-1,442	-1,295	-1,244	-1,481	-1,564	-1,400
Net Debt Issued (Repaid)	1,356	1,121	954.32	21.62	7.14	-212.25
Issuance of Common Stock	-	-	-	-	-	401.86
Common Dividends Paid	-471.94	-467.57	-449.86	-440.11	-402.22	-55.72
Other Financing Activities	-278.67	-288.25	-499.79	85.29	-148.5	-95.85
Financing Cash Flow	605.74	365.48	4.67	-333.2	-543.58	38.04

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Foreign Exchange Rate Adjustments	-12.45	-9.73	2.21	0.72	5.87	-1.18
Net Cash Flow	675.78	701.4	88.4	171.31	-349.29	195.33

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Free Cash Flow	348.15	645.52	509.86	614.01	200.43	153.81
Free Cash Flow Growth	-40.72%	26.61%	-16.96%	206.34%	30.31%	-
Free Cash Flow Margin	4.67%	8.60%	6.30%	7.44%	2.67%	2.18%
Free Cash Flow Per Share	0.65	1.21	0.94	1.15	0.38	0.31
Levered Free Cash Flow	-1.47	383.26	791.34	340.46	171.77	45.79
Unlevered Free Cash Flow	67.61	448.04	841.39	385.29	208.06	83.96

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Cash Income Tax Paid	636.25	641.35	632.97	600.08	459.8	384.21
Change in Working Capital	170.59	170.59	-87.55	-124.17	-316.12	-338.47

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error